Background The synthetic opioid tramadol is widely used as a pain reliever. Unlike other opioids, it is used freely worldwide, unaffected by international controls resulting in abuse and accidental intoxication. Analytical methods are necessary to prove tramadol abuse because 30% of the drug is excreted unchanged. Methodology This study describes a sensitive, precise, and accurate gas chromatograph-mass spectrometry (GC-MS) method for tramadol quantification in biological samples using solid-phase extraction (SPE) for sample preparation. Results A total of 747 samples were analyzed for suspected tramadol abuse; 15% of samples were above cut-off with a mean of 341.0 ± 215 ng/mL. No interference from other substances was detected. Calibration was linear over the concentration range of 50-1,000 ng/mL with a correlation coefficient of >0.998. Recovery was 92.5% and precision was ≤5% (range = 2.68-5.58%). Conclusions The effectiveness of the SPE in assessing tramadol abuse was assessed with GC-MS. With good recovery, quick analysis times, simplicity, little matrix effect, and effectiveness, this method is regarded as novel and is capable of identifying abuse.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11711240PMC
http://dx.doi.org/10.7759/cureus.75424DOI Listing

Publication Analysis

Top Keywords

tramadol abuse
16
tramadol
6
abuse
6
gas chromatography-mass
4
chromatography-mass spectrometry
4
spectrometry method
4
method determine
4
determine tramadol
4
abuse urine
4
samples
4

Similar Publications

Background The synthetic opioid tramadol is widely used as a pain reliever. Unlike other opioids, it is used freely worldwide, unaffected by international controls resulting in abuse and accidental intoxication. Analytical methods are necessary to prove tramadol abuse because 30% of the drug is excreted unchanged.

View Article and Find Full Text PDF

Patterns of Opioid and NSAID Use in Saudi Arabia from 2010 to 2020.

J Psychoactive Drugs

January 2025

Department of Pharmaceutical Care, King Fahad Medical City, Riyadh, Saudi Arabia.

The use of analgesics has increased globally over the last three decades. Prescription drug abuse has increased significantly, and opioids have been identified as causing further harm to the world. This study explored the utilization and expenditure associated with opioids and non-steroidal anti-inflammatory drugs (NSAIDs) from 2010 to 2020 in Saudi Arabia.

View Article and Find Full Text PDF

Children are highly sensitive to toxins which can damage their organs and lead to death. Investigating the main causes of intoxication could reduce mortality and morbidity in children. In this cross-sectional study, the documents of all poisoned patients (214 cases) admitted to the emergency department of Taleghani children`s Hospital between April 2020 and 2023 were investigated.

View Article and Find Full Text PDF

Tramadol as a fentanyl adulterant: Prevalence and management in a ToxIC Fentalog study prospective cohort.

Am J Emerg Med

December 2024

Icahn School of Medicine at Mount Sinai, Center for Research on Emerging Substances, Poisoning, Overdose, and New Discoveries (RESPOND), NYC Health + Hospitals/Elmhurst, New York, NY, USA.

Background: Tramadol is an adulterant of illicit opioids. As it is a serotonin-norepinephrine reuptake inhibitor as well as a μ-opioid agonist, tramadol adulteration may worsen overdose signs and symptoms or affect the amount of naloxone patients receive.

Methods: This is a multicenter, prospective cohort of adult patients with suspected opioid overdoses who presented to one of eight United States emergency departments and were included in the Toxicology Investigators Consortium's Fentalog Study.

View Article and Find Full Text PDF

Patient characteristics in relation to opioid exposure in a chronic non-cancer pain population.

Scand J Pain

January 2024

Department of Clinical Sciences Malmö, Center for Primary Health Care Research, Lund University, Jan Waldenströms Gata 35, 202 13 Malmö, Sweden.

Objectives: The efficacy of long-term opioid therapy (LTOT) in treating patients with chronic non-cancer pain (CnCP) is questionable, and the potential risks of adverse effects are well established. The aims were as follows: (1) compare characteristics in patients exposed to LTOT vs non-exposed. (2) Regarding opioid-exposed patients, describe characteristics of patients with risk factors for opioid use disorder or overdose in relation to opioid dosage.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!